Theriva Biologics, Inc.TT

Theriva Biologics, Inc.

1.71USDR
−0.01−0.87%
At close at Feb 15, 00:33 GMT
USD
No trades
See on Supercharts

Price target

6.00RUSD+4.30+251.91%
The 1 analyst offering 1 year price forecasts for Theriva Biologics, Inc. have a max estimate of 6.00 and a min estimate of 6.00.

Analyst rating

Based on 1 analyst giving stock ratings to Theriva Biologics, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
1
Buy
0
Hold
0
Sell
0
Strong sell
0

EPS

Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−12.00‬
‪−9.00‬
‪−6.00‬
‪−3.00‬
‪0.00‬
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
‪−7.50‬
‪−8.50‬
‪−4.75‬
‪−7.75‬
‪−7.50‬
‪−10.75‬
‪−6.81‬
Estimate
‪−8.88‬
‪−9.00‬
‪−10.50‬
‪−10.25‬
‪−4.75‬
‪−4.75‬
‪−6.25‬
‪−7.22‬
Surprise
+15.49%
+5.56%
+54.76%
+24.39%
−57.89%
−126.32%
−8.96%

Revenue

Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


TOVX EPS for the last quarter is −6.81 USD despite the estimation of −6.25 USD. In the next quarter EPS is expected to reach −7.22 USD. Track more of Theriva Biologics, Inc. financials and stay on top of what is up with the company.
According to analysts, TOVX price target is 6.00 USD with a max estimate of 6.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Theriva Biologics, Inc. stock price chart and keep track of the current situation with TOVX news and stock market news.